公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2002 | Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 142 | 138 | |
2007 | OncoDB.HCC: An integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci | Su W.-H.; Chao C.-C.; Shiou-Hwei Yeh ; DING-SHINN CHEN ; PEI-JER CHEN ; Jou Y.-S. | Nucleic Acids Research | 86 | 78 | |
2009 | Oncolytic virotherapy for advanced liver tumours | Chang J.-F.; PEI-JER CHEN ; Sze D.Y.; Reid T.; Bartlett D.; Kirn D.H.; Liu T.-C. | Journal of Cellular and Molecular Medicine | 15 | 14 | |
2013 | One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor | PEI-JER CHEN ; Wu T.-C. | Cell and Bioscience | 6 | 5 | |
2017 | One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature | Chen Y.-J.; Dela Rosa M.A.C.; Chen W.-C.; Chen Y.-J.; Obena R.P.; Chang C.-H.; Capangpangan R.Y.; TUNG-HUNG SU ; CHI-LING CHEN ; PEI-JER CHEN | Analytical Chemistry | 21 | 21 | |
1999 | Opportunistic hepatic infections in aids patients with fever of unknown origin | Chang Y.-G.; PEI-JER CHEN ; CHIEN-CHING HUNG ; Chen M.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 4 | |
2023 | Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria | Huang, Chian Tzu; Chu, Yu Long; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Liver Cancer | | | |
2020 | The origin and underlying driving forces of the SARS-CoV-2 outbreak | Chaw, Shu-Miaw; Tai, Jui-Hung; Chen, Shi-Lun; Hsieh, Chia-Hung; SUI-YUAN CHANG ; Shiou-Hwei Yeh ; WEI-SHIUNG YANG ; PEI-JER CHEN ; HURNG-YI WANG | Journal of biomedical science | 65 | 57 | |
2004 | Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation | CHUN-JEN LIU ; JIA-HORNG KAO ; HURNG-YI WANG ; Lai M.-Y.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 17 | 17 | |
2006 | Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of Viral Hepatitis | 14 | 12 | |
2002 | p53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia | Chen Y.-W.; YUNG-MING JENG ; Shiou-Hwei Yeh ; PEI-JER CHEN | Hepatology | 115 | 113 | |
1998 | P53 mutation in advanced stage of primary myelodysplastic syndrome | JIH-LUH TANG ; HWEI-FANG TIEN ; Lin M.-T.; PEI-JER CHEN ; YAO-CHANG CHEN | Anticancer Research | 7 | 5 | |
1994 | Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: Different roles for the small and large delta antigens | Wang H.-W.; PEI-JER CHEN ; Lee, Cha-Ze ; Wu H.L.; DING-SHINN CHEN | Journal of Virology | 38 | 37 | |
2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
2020 | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan | Su H.-J.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 17 | 12 | |
2004 | Patient Data, Early SARS Epidemic, Taiwan | PO-REN HSUEH ; PEI-JER CHEN ; Hsiao C.-H.; Yeh S.-H.; WERN-CHERNG CHENG ; Wang J.-L.; BOR-LUEN CHIANG ; SHAN-CHWEN CHANG ; Chang F.-Y.; Wong W.-W.; CHUAN-LIANG KAO ; PAN-CHYR YANG ; DING-SHINN CHEN ; Lee Y.-T.; Teng C.-M.; HONG-NERNG HO ; MING-FU CHANG ; Wang J.-T.; Wang W.-K. | Emerging Infectious Diseases | 65 | 54 | |
2012 | PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model | Tzeng H.-T.; Tsai H.-F.; Liao H.-J.; Lin Y.-J.; Chen L.; PEI-JER CHEN ; PING-NING HSU | PLoS ONE | 120 | 111 | |
2017 | Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients | Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN ; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S. | Frontiers in Immunology | 51 | 42 | |
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |
2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |